Valuation: Elanco Animal Health Incorporated

Capitalization 10.78B 9.26B 8.69B 8.09B 14.91B 968B 16.2B 101B 39.15B 459B 40.44B 39.58B 1,691B P/E ratio 2025 *
1,627x
P/E ratio 2026 * 146x
Enterprise value 14.25B 12.25B 11.49B 10.71B 19.71B 1,281B 21.43B 133B 51.78B 607B 53.49B 52.35B 2,236B EV / Sales 2025 *
3.05x
EV / Sales 2026 * 2.81x
Free-Float
99.34%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.40%
1 week-9.16%
Current month-12.20%
1 month-4.93%
3 months+8.90%
6 months+46.77%
Current year+68.70%
More quotes
1 week 20.41
Extreme 20.41
22.19
1 month 20.41
Extreme 20.41
23.7
Current year 8.02
Extreme 8.02
23.7
1 year 8.02
Extreme 8.02
23.7
3 years 7.88
Extreme 7.88
23.7
5 years 7.88
Extreme 7.88
37.49
10 years 7.88
Extreme 7.88
37.61
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 2018-06-30
Director of Finance/CFO 49 2025-07-06
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 57 2018-06-30
Chairman 79 2018-04-30
Director/Board Member 71 2018-08-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-5.81%-9.16%+58.62%+61.25% 10.78B
-2.04%-6.98%-35.03%-24.54% 52.07B
-0.88%-1.10%-19.46%+0.11% 3.44B
-2.15%-5.67%+6.90%+42.08% 3.39B
-0.21%+15.34%+105.44%+57.46% 2.22B
-0.73%-0.54%-29.44%-9.49% 1.68B
-4.49%-5.90%+64.15%+201.65% 1.62B
-1.45%-3.73%-4.88%-8.88% 1.24B
+1.36%+7.33%+14.21%-33.12% 1.17B
-0.26%+5.91%-1.28%-8.22% 1.06B
Average -1.22%+0.55%+15.92%+27.83% 7.87B
Weighted average by Cap. -1.79%-5.01%-11.91%-1.19%
See all sector performances

Financials

2025 *2026 *
Net sales 4.67B 4.01B 3.76B 3.51B 6.46B 420B 7.02B 43.65B 16.96B 199B 17.52B 17.15B 733B 4.92B 4.23B 3.96B 3.69B 6.8B 442B 7.39B 45.97B 17.87B 209B 18.45B 18.06B 772B
Net income 7.42M 6.37M 5.98M 5.57M 10.26M 666M 11.15M 69.33M 26.95M 316M 27.83M 27.24M 1.16B 225M 194M 182M 169M 312M 20.24B 339M 2.11B 818M 9.59B 845M 827M 35.35B
Net Debt 3.48B 2.99B 2.8B 2.61B 4.81B 312B 5.23B 32.49B 12.63B 148B 13.04B 12.77B 545B 3.05B 2.62B 2.46B 2.29B 4.23B 274B 4.59B 28.56B 11.1B 130B 11.46B 11.22B 479B
More financial data * Estimated data
Logo Elanco Animal Health Incorporated
Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Employees
9,225
More about the company
Date Price Change Volume
25-12-09 20.43 $ -5.81% 11,209,827
25-12-08 21.69 $ -0.96% 6,063,972
25-12-05 21.90 $ -0.41% 3,663,803
25-12-04 21.99 $ -0.86% 5,885,762
25-12-03 22.18 $ -1.38% 6,481,844

Delayed Quote Nyse, December 09, 2025 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
21.69USD
Average target price
24.62USD
Spread / Average Target
+13.49%
Consensus

Quarterly revenue - Rate of surprise